Oxaprozin and Pancreatitis - a phase IV clinical study of FDA data

Summary:

Pancreatitis is reported as a side effect among people who take Oxaprozin (oxaprozin), especially for people who are female, 40-49 old, also take Prednisone, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Pancreatitis when taking Oxaprozin. It is created by eHealthMe based on reports of 1,532 people who have side effects when taking Oxaprozin from the FDA, and is updated regularly.

What is Oxaprozin?

Oxaprozin has active ingredients of oxaprozin. It is often used in joint pain. eHealthMe is studying from 1,578 Oxaprozin users. Check the latest studies of Oxaprozin.

What is Pancreatitis?

Pancreatitis (inflammation of pancreas) is found to be associated with 1,766 drugs and 2,024 conditions by eHealthMe. Check the latest studies of Pancreatitis.

On Jul, 07, 2026

1,532 people reported to have side effects when taking Oxaprozin.
Among them, 13 people (0.85%) have Pancreatitis.

Among these 13 people:

What is the gender of people who have Pancreatitis when taking Oxaprozin? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Pancreatitis when taking Oxaprozin? *

What are other drugs people take besides Oxaprozin? *

Prednisone: 5 people, 38.46%
Prozac: 3 people, 23.08%
Lipitor: 3 people, 23.08%
Cymbalta: 3 people, 23.08%
Xanax: 3 people, 23.08%
Fluticasone Propionate: 3 people, 23.08%
Avandamet: 3 people, 23.08%
Seroquel: 3 people, 23.08%
Prevacid: 2 people, 15.38%
Zantac: 2 people, 15.38%

What are other side effects people have besides Pancreatitis? *

Acute Kidney Failure: 5 people, 38.46%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 5 people, 38.46%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 30.77%
Weight Decreased: 3 people, 23.08%
Nosocomial Infection (infection from hospital): 3 people, 23.08%
Foot Ulcer: 3 people, 23.08%
Diabetes: 3 people, 23.08%
Dermatitis Lichenoid (lichen simplex chronicus is a chronic inflammation of the skin): 3 people, 23.08%
Dehydration (dryness resulting from the removal of water): 3 people, 23.08%
Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 23.08%

What are the existing conditions these people have? *

Sleep Disorder: 2 people, 15.38%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
High Blood Cholesterol: 2 people, 15.38%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 2 people, 15.38%
Bipolar Disorder (mood disorder): 2 people, 15.38%
Weight Loss: 1 person, 7.69%
Stress And Anxiety: 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Oxaprozin and have Pancreatitis?

- Check whether Pancreatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxaprozin:

Oxaprozin (1,578 reports)

Pancreatitis treatments and more:

Pancreatitis (62,704 reports)

Browse all side effects of Oxaprozin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis:

Pancreatitis (1,766 drugs)

Browse all the conditions that are associated with Pancreatitis:

Pancreatitis (2,024 conditions)

Related publications that referenced our studies

Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on oxaprozin (the active ingredients of Oxaprozin) and Oxaprozin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.